Condition: Heart Failure · Primary Prevention of Sudden Cardiac Death · Implantable Cardioverter Defibrillator · Sponsor: Assistance Publique - Hôpitaux de Paris
The primary objective of DILEMMA study is to assess whether the "heart failure optimal therapy alone (HFOT)" strategy is non inferior to the "HFOT+ICD" strategy in terms of overall survival 48 months after randomization, in patients ≥ 70 years with an ICD indication for primary prevention of SCD whether there is an indication for cardiac resynchronization therapy or not.
This description comes directly from the study's public registry record.
Alexandra BRUNEAU, Mrs · +33144841712 · alexandra.bruneau@aphp.fr
Eloi MARIJON, MD, PhD · +33156093692 · eloi.marijon@aphp.fr
Always discuss trial participation with your own doctor first.
| Centre Hospitalier d'Aix en provence | Aix-en-Provence, France | Recruiting |
| CHU Amiens-Picardie-Site sud | Amiens, France | Recruiting |
| CHU Brest - Hôpital La Cavale Blanche | Brest, France | Recruiting |
| HôpitalHenri Mondor | Créteil, France | Recruiting |
| CHU Grenoble Alpes | La Tronche, France | Recruiting |
| Groupement d'Hôpitaux de l'Institut Catholique de Lille | Lomme, France | Recruiting |
| Hôpital de La Timone | Marseille, France | Recruiting |
| Hôpital de Brabois | Nancy, France | Recruiting |
| CHU de Nantes | Nantes, France | Recruiting |
| Hôpital européen Georges Pompidou | Paris, France | Recruiting |
| Hôpital Pitié-Salpétrière | Paris, France | Recruiting |
| Hôpital Bichat - Claude Bernard | Paris, France | Recruiting |
+ 7 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05373940